Literature DB >> 1945882

A simple procedure for the preparation of protected 2'-O-methyl or 2'-O-ethyl ribonucleoside-3'-O-phosphoramidites.

E Wagner1, B Oberhauser, A Holzner, H Brunar, G Issakides, G Schaffner, M Cotten, M Knollmüller, C R Noe.   

Abstract

Protected 2'-O-methyl and 2'-O-ethyl ribonucleoside-3'-O-phosphoramidites were prepared via alkylation of the ribonucleosides at an early stage in the synthesis. Utilizing a strategy of minimal protection, the alkylation was performed with unprotected cytidine and adenosine, or with O6-protected guanosine and N3,5'-O-protected uridine using methyl or ethyl iodide and sodium hydride. In subsequent steps, the introduction of standard protective groups for oligonucleotide synthesis and the concomitant separation from 3'-O-alkylated isomers was accomplished. A modification of the phosphitylation procedure permitted facile isolation of the desired phosphoramidites which show high coupling efficiencies in oligomer assembly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945882      PMCID: PMC329054          DOI: 10.1093/nar/19.21.5965

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Probing the structure and function of U2 snRNP with antisense oligonucleotides made of 2'-OMe RNA.

Authors:  A I Lamond; B Sproat; U Ryder; J Hamm
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

2.  Site-directed cleavage of RNA.

Authors:  S Shibahara; S Mukai; T Nishihara; H Inoue; E Ohtsuka; H Morisawa
Journal:  Nucleic Acids Res       Date:  1987-06-11       Impact factor: 16.971

3.  Antisense probing of the human U4/U6 snRNP with biotinylated 2'-OMe RNA oligonucleotides.

Authors:  B J Blencowe; B S Sproat; U Ryder; S Barabino; A I Lamond
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

4.  Synthesis of O2'-methyluridine, O2'-methylcytidine, N4,O2'-dimethylcytidine and N4,N4,O2'-trimethylcytidine from a common intermediate.

Authors:  A Nyilas; J Chattopadhyaya
Journal:  Acta Chem Scand B       Date:  1986-11

5.  Synthesis and hybridization studies on two complementary nona(2'-O-methyl)ribonucleotides.

Authors:  H Inoue; Y Hayase; A Imura; S Iwai; K Miura; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

6.  Synthesis and structure assignments of amide protected nucleosides and their use as phosphoramidites in deoxyoligonucleotide synthesis.

Authors:  M Mag; J W Engels
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

7.  Highly efficient chemical synthesis of 2'-O-methyloligoribonucleotides and tetrabiotinylated derivatives; novel probes that are resistant to degradation by RNA or DNA specific nucleases.

Authors:  B S Sproat; A I Lamond; B Beijer; P Neuner; U Ryder
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

8.  Synthesis and properties of novel nucleic acid probes.

Authors:  H Inoue; Y Hayase; M Asaka; A Imura; S Iwai; K Miura; E Ohtsuka
Journal:  Nucleic Acids Symp Ser       Date:  1985

9.  New synthetic routes to protected purine 2'-O-methylriboside-3'-O-phosphoramidites using a novel alkylation procedure.

Authors:  B S Sproat; B Beijer; A Iribarren
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

10.  Mapping U2 snRNP--pre-mRNA interactions using biotinylated oligonucleotides made of 2'-OMe RNA.

Authors:  S M Barabino; B S Sproat; U Ryder; B J Blencowe; A I Lamond
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  2 in total

1.  Effective incorporation of 2'-O-methyl-oligoribonucleotides into liposomes and enhanced cell association through modification with thiocholesterol.

Authors:  B Oberhauser; E Wagner
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

Review 2.  Nucleic Acids and Their Analogues for Biomedical Applications.

Authors:  Fei Wang; Pan Li; Hoi Ching Chu; Pik Kwan Lo
Journal:  Biosensors (Basel)       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.